In patients with suspected breast implant-associated anaplastic large-cell lymphoma, cytologic evaluation of fine-needle aspirate specimens from the peri-implant seroma, together with flow cytometric immunophenotyping and immunohistochemistry, represents a suitable preoperative diagnostic approach when planning for surgical management.
A 50-year-old woman with a history of left breast cancer, treated with mastectomy and radiation therapy followed by breast reconstruction with textured silicone-gel implants five years prior, presented with new-onset left breast swelling. Microscopic examination of aspirated periprosthetic fluid revealed large, pleomorphic cells ( Figure 1A-D) . By flow cytometry ( Figure 1E ; abnormal cells: blue; normal CD4+ T cells: green; normal CD8+ T cells: red), most of the cells were CD45+ leukocytes with abnormally high side scatter (SSC). The abnormal cells were positive for CD30, and expressed several T-cell antigens (CD2, CD5, CD7, and CD8; Figure 1E and not shown), but were CD3-( Figure  1E ). PCR studies demonstrated clonal T-cell receptor γ-chain gene rearrangement. A diagnosis of breast implantassociated anaplastic large-cell lymphoma was made. The subsequently excised periprosthetic capsule ( Figure 1F ,G) contained large, pleomorphic cells between a layer of eosinophilic material adjacent to the capsular lumen and the underlying capsule. By immunohistochemistry, the neoplastic cells were positive for CD30 ( Figure 1H ); ALK-1 was negative (not shown).
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a recently recognized provisional diagnostic entity in the Revised 4th Edition of the WHO classification of lymphoid neoplasms. 1 This rare form of Tcell non-Hodgkin lymphoma, which appears to be related to textured implants, arises after a highly variable latency that averages approximately 10 years. 
